Organovo Holdings, Inc.
(NASDAQ : ONVO)

( )
ONVO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
0.61%284.001.4%$846.81m
AMGNAmgen, Inc.
0.11%221.101.3%$516.31m
CELGCelgene Corp.
-0.03%109.991.3%$466.64m
GILDGilead Sciences, Inc.
-0.29%64.881.0%$399.18m
VRTXVertex Pharmaceuticals, Inc.
2.34%209.801.9%$313.89m
ILMNIllumina, Inc.
-1.10%302.613.5%$307.88m
REGNRegeneron Pharmaceuticals, Inc.
1.92%344.872.6%$267.68m
EXASEXACT Sciences Corp.
3.55%82.0524.0%$209.78m
ALXNAlexion Pharmaceuticals, Inc.
2.34%108.372.0%$179.80m
SGENSeattle Genetics, Inc.
1.29%114.756.1%$136.96m
BMRNBioMarin Pharmaceutical, Inc.
-0.71%75.044.3%$123.64m
SRPTSarepta Therapeutics, Inc.
0.05%97.4614.6%$115.38m
AAgilent Technologies, Inc.
1.95%78.261.6%$101.36m
NBIXNeurocrine Biosciences, Inc.
2.89%113.055.0%$90.40m
BGNEBeiGene Ltd.
0.94%198.252.1%$88.64m

Company Profile

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.